Doctors Co., Ltd. announced that it expects to receive funding from Suzuken Co., Ltd.
November 25, 2021
Share
Doctors Co., Ltd. announced that it will receive an equity round of funding from returning investor Suzuken Co., Ltd. on November 26, 2021. The company will raise the funding through third-party allotment method. Post closing, the investor's stake in the company will increase from 7% to 9%.
The transaction is expected to close on November 30, 2021.
Suzuken Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in four business segments. The Pharmaceutical Wholesale segment sells pharmaceuticals, diagnostic drugs, and medical equipment and materials, among others. The Pharmaceutical Manufacturing segment manufactures pharmaceuticals and diagnostic drugs and others. The Insurance Pharmacy segment is engaged in dispensing operations based on prescriptions from medical institutions. The Medical-related Service and Others segment is engaged in the provision of manufacturer support services, such as the transportation of medicines and comprehensive support for the distribution of drugs for rare diseases; the nursing services; the manufacture of physiological examination equipment, such as electrocardiographic monitors and blood pressure monitors; as well as other services, such as the sale of medical books.
SUZUKEN CO., LTD. 
